You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lipid Marker

Showing 1 - 25 of 6,874
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lipid Profile in Acute Coronary Syndrome

Not yet recruiting
  • Acute Coronary Syndrome
  • Triglycerides/high density lipoprotein ratio
  • (no location specified)
Nov 17, 2021

Hyperthyroidism, Graves Disease, Atherosclerosis of Artery Trial in Jakarta Pusat (Propylthiouracil, Methimazole)

Completed
  • Hyperthyroidism
  • +3 more
  • Jakarta Pusat, Jakarta, Indonesia
    University of Indonesia
Nov 11, 2021

Adherence, Treatment Trial in Davis (lipid-based nutrient supplement containing adherence markers, lipid-based nutrient

Completed
  • Adherence, Treatment
  • lipid-based nutrient supplement containing adherence markers
  • +2 more
  • Davis, California
    University of California, Davis
Jan 7, 2021

Early Complications in Type 1 Diabetes Mellitus

Not yet recruiting
  • Diabetes Mellitus, Type 1
    • (no location specified)
    Feb 12, 2023

    HIV Infection, Combined Antiretroviral Therapy Trial in Hangzhou

    Recruiting
    • HIV Infection
    • Combined Antiretroviral Therapy
      • Hangzhou, Zhejiang, China
        Zhikai Wan
      Aug 30, 2023

      ALSFTD Trial in Montréal (Probiotic, Placebo)

      Not yet recruiting
      • ALSFTD
      • Probiotic
      • Placebo
      • Montréal, Quebec, Canada
        Centre Hospitalier de l'Université de Montréal
      Sep 18, 2023

      Diet, Healthy Trial in Kajang (A 12-week parallel dietary intervention)

      Completed
      • Diet
      • Healthy
      • A 12-week parallel dietary intervention
      • Kajang, Selangor, Malaysia
        Malaysian Palm Oil Board
      Mar 28, 2023

      Short Bowel Syndrome, Intestinal Fistula, Crohn Disease Trial in Rochester (SMOFLipid, Intralipid)

      Active, not recruiting
      • Short Bowel Syndrome
      • +3 more
      • SMOFLipid
      • Intralipid
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 6, 2023

      Fatty Liver Trial in Giza (laser acupuncture, wet cupping)

      Recruiting
      • Fatty Liver
      • laser acupuncture
      • wet cupping
      • Giza, Egypt
        Cairo Unoversity
      Nov 18, 2022

      MDS, Cardiovascular Diseases, Inflammation Trial in Toronto (Genetic Mutations, Inflammatory and lipid markers, Computed

      Unknown status
      • MDS
      • +2 more
      • Genetic Mutations
      • +2 more
      • Toronto, Ontario, Canada
        Sunnybrook Health Sciences Centre
      Sep 30, 2019

      Coronary Artery Calcification, Metabolic Syndrome, Dyslipidemias Trial (Guideline directed statin therapy, High intensity statin

      Not yet recruiting
      • Coronary Artery Calcification
      • +2 more
      • Guideline directed statin therapy
      • High intensity statin plus ezetimibe therapy
      • (no location specified)
      Apr 25, 2023

      Diabetes, Type 2 Trial in Kuching (Sago starch drink, Corn starch drink)

      Recruiting
      • Diabetes Mellitus, Type 2
      • Sago starch drink
      • Corn starch drink
      • Kuching, Sarawak, Malaysia
      • +3 more
      Jan 29, 2023

      The Genetic, Protein, and Lipid Basis of Variation in

      Active, not recruiting
      • Lipid Metabolism Disorders
        • Dallas, Texas
          UT Southwestern Medical Center
        Dec 21, 2022

        Diabetic Nephropathy Type 2 Trial (Tadalafil 20Mg Oral Tablet, Pentoxifylline 400 MG Oral Tablet)

        Not yet recruiting
        • Diabetic Nephropathy Type 2
        • Tadalafil 20Mg Oral Tablet
        • Pentoxifylline 400 MG Oral Tablet
        • (no location specified)
        Aug 2, 2022

        Lymphedema Trial in Nice (lipoprotein (a))

        Not yet recruiting
        • Lymphedema
        • lipoprotein (a)
        • Nice, Centre Antoine Lacassagne, France
          CAUSERET Marion
        Jul 19, 2023

        Novel Cardiovascular Biomarkers in Patients With Kidney Disease

        Not yet recruiting
        • Haemodialysis Complication
        • Major Adverse Cardiac Events
        • Cardiac Biomarkers
        • +2 more
        • (no location specified)
        Sep 14, 2023

        Metabolic Syndrome Trial in Madrid (Experimental: Group 1: Spirulina platensis, Experimental: Group 2: Chlorella vulgaris,

        Completed
        • Metabolic Syndrome
        • Experimental: Group 1: Spirulina platensis
        • +2 more
        • Madrid, Spain
          Institute for Health Research IdiPAZ
        May 5, 2022

        Dry Eye, Dry Eye Syndromes, Cataract Trial in Brampton (dietary supplement, drug, other)

        Not yet recruiting
        • Dry Eye
        • +2 more
        • Omega-3
        • +3 more
        • Brampton, Ontario, Canada
          Uptown Eye
        Aug 6, 2023

        Urinary Uromodulin and Corresponding Urinary Exosomal UMOD mRNA

        Completed
        • Diabetic Nephropathy, Urinary Uromodulin, Exosomal UMOD mRNA Gene Expression
        • ACR, fasting, postprandial blood glucose ,HbA1c, creatinine, cystatin-C, BUN, Na, K , lipid profile
        • Tanta, Al Gharbia, Egypt
          Tanta university hospital, faculty of science, tanta university
        Jan 24, 2023

        Overweight, Obesity Trial in Grand Forks (Control Diet, Med Diet, Med Diet + Whole Egg)

        Terminated
        • Overweight
        • Obesity
        • Control Diet
        • +2 more
        • Grand Forks, North Dakota
          USDA Grand Forks Human Nutrition Research Center
        Aug 1, 2022

        Postemenopusal Women With Osteopenia Trial in Seoul (Raloxifene plus cholecalciferol, Cholecalciferol)

        Recruiting
        • Postemenopusal Women With Osteopenia
        • Seoul, Korea, Republic of
          Yonsei University Health System, Severance Hospital
        May 22, 2022

        The Hellenic Postprandial Lipemia Study (HPLS)

        Completed
        • Coronary Heart Disease
        • Dyslipidemia
          • Athens, Greece
            Onassion Cardiology Hospital
          Aug 28, 2019

          Hyperlipidemias Trial in Cambridge (PocDoc)

          Completed
          • Hyperlipidemias
          • PocDoc
          • Cambridge, United Kingdom
            Vital Signs Solutions Ltd
          Sep 18, 2023

          Diabetes Type 2 Trial in Seongnam (Dapagliflozin 10mg Tab, Lobeglitazone 0.5 mg, Dapagliflozin + Lobeglitazone)

          Recruiting
          • Diabetes Type 2
          • Dapagliflozin 10mg Tab
          • +2 more
          • Seongnam, Gyeonggi, Korea, Republic of
            Seoul National University Bundang Hospital
          Jun 14, 2023

          The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive

          Completed
          • The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive Patients
          • Zingiber officinale L. tablets
          • Simvastatin 20mg
          • Karachi, Sindh, Pakistan
            Alkhidmat Hospital
          Jan 11, 2023